SNP combinations in chromosome-wide genes are associated with bone mineral density in Taiwanese women

Chinese Journal of Physiology

Volumn 51, Issue 1, 2008, Pages 32-41

  Lin, Gau Tyan ^a,b,j   Tseng, Hung Fu ^c   Chang, Chen Kang ^d   Chuang, Li Yeh ^e   Liu, Chih Shan ^f   Yang, Cheng Hong ^g   Tu, Chung Jui ^g   Wang, Eng Chi ^f   Tan, Hsiu Fen ^h   Chang, Chia Che ⁱ   Wen, Cheng Hao ^f   Chen, Hsiang Chi ^f   Chang, Hsueh Wei ^f  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY OF SPORT   (Taiwan)

^e I SHOU UNIVERSITY   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^g NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^h CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

ⁱ NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^j KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

more..

Author keywords

Association; BMD; BMI; Osteoporosis; SNP interaction

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CYTOSINE; GENOMIC DNA; HEAT SHOCK PROTEIN 70; INTERLEUKIN 1; OSTEOCALCIN; PARATHYROID HORMONE; THYMINE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; CHROMOSOME 11; CHROMOSOME 6; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PATHOGENESIS; POSTMENOPAUSE; PREMENOPAUSE; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; WOMEN'S HEALTH; AGE; GENETICS; MIDDLE AGED;

ADULT; AGE FACTORS; BODY MASS INDEX; BONE DENSITY; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; HUMANS; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; OSTEOPOROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 46449099859     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Aberle, J., Hopfer, I., Beil, F.U. and Seedorf, U. Association of peroxisome proliferator-activated receptor delta +294T/C with body mass index and interaction with peroxisome proliferator-activated receptor alpha L162V. Int. J. Obes. (Lond) 30: 1709-1713, 2006.
2. Baier, R.J., Loggins, J. and Yanamandra, K. IL-10, IL-6 and CD14 polymorphisms and sepsis outcome in ventilated very low birth weight infants. BMC Med. 4: 10, 2006.
3. Bandres, E., Pombo, I., Gonzalez, Huarriz, M., Rebollo, A., Lopez, G. and Garcia-Foncillas, I. Association between bone mineral density and polymorphisms of the VDR, ERalpha, COL1A1 and CTR genes in Spanish postmenopausal women. J. Endocrinol. Invest. 28: 312-321, 2005.
4. Camozzi, V., Carraro, V., Zangari, M., Fallo, F., Mantero, F. and Luisetto, G. Use of quantitative ultrasound of the hand phalanges in the diagnosis of two different osteoporotic syndromes: Cushing's syndrome and postmenopausal osteoporosis. J. Endocrinol. Invest. 27: 510-515, 2004.
5. Chan, W.B., Tong, P.C., Chow, C.C., So, W.Y., Ng, M.C., Ma, R.C., Osaki, R., Coekram, C.S. and Chan, J.C. The associations of body mass index, C-peptide and metabolic status in Chinese Type 2 diabetic patients. Diabet. Med. 21: 349-353, 2004.
6. Chang, H.W., Lee; S.M., Goodman, S.N., Singer, G., Cho, S.K., Sokoll, L.J., Montz, F.J., Roden, R., Zhang, Z., Chan, D.W., Kurman, R.J. and Shih, I.M. Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer. J. Natl. Cancer Inst. 94: 1697-1703, 2002.
7. Chang, H.W., Yang, C.H., Chang; P.L., Cheng, Y.H. and Chuang, L.Y. SNP-RFLPing: restriction enzyme mining for SNPs in genomes. BMC Genomics 7: 30, 2006.
8. Chang, H.W., Yen, C.Y., Liu, S.Y., Singer, G. and Shih, I.M. Genotype analysis using human hair shaft. Cancer Epidemiol. Biomarkers Prev. 11: 925-929, 2002.
9. Dohi, Y., Iki, M., Ohgushi, H., Gojo, S., Tabata, S., Kajita, E., Nishino, H. and Yonemasu, K. A novel polymorphism in the promoter region for the human osteocalcin gene: the possibility of a correlation with bone mineral density in postmenopausal Japanese women. J. Bone Miner. Res. 13: 1633-1639, 1998.
10. Drews, K., Seremak-Mrozikiewicz, A., Bartkowiak-Wieczorek, J., Pienkowski, W., Dubiel, M. and Mrozikiewicz, P.M. Genetic polymorphism of the calcitonin receptor gene and bone mineral density in Polish population of postmenopausal women. Ginekol. Pol. 76: 612-618, 2005.
11. Dmmmond, F.J., Mackrill, JJ., O'Sullivan, K., Daly, M., Shanahan, F. and Molloy, M.G. CD38 is associated with premenopausal and postmenopausal bone mineral density and postmenopausal bone loss. J. Bone Miner. Metab. 24: 28-35, 2006.
12. Feng, X., Bonni, S. and Riabowol, K. HSP70 induction by ING proteins sensitizes cells to tumor necrosis factor alpha receptor-mediated apoptosis. Mol. Cell. Biol. 26: 9244-9255, 2006.
13. Furuta, I., Kobayashi, N., Fujino, T., Kobamatsu, Y., Shirogane, T., Yaegashi, M., Sakuragi, N., Cho, K., Yamada, H., Okuyama, K. and Minakami, H. Bone mineral density of the lumbar spine is associated with TNF gene polymorphisms in early postmenopausal Japanese women. Calcif. Tissue Int. 74: 509-515, 2004.
14. Giguere, Y. and Rousseau, F. The genetics of osteoporosis: 'complexities and difficulties'. Clin. Genet. 57: 161-169, 2000.
15. Hogan, B.L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10: 1580-1594, 1996.
16. Hong, S., Lim, S., Li, A.G., Lee, C., Lee, Y.S., Lee, E.K., Park, S.H., Wang, X.J. and Kim, S.J. Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nat. Immunol. 8: 504-513, 2007.
17. Hosoi, T., Miyao, M., Inoue, S., Hoshino, S., Shiraki, M., Orimo, H. and Ouchi, Y. Association study of parathyroid hormone gene polymorphism and bone mineral density in Japanese postmenopausal women. Calcif. Tissue Int. 64: 205-208, 1999.
18. Hughes, D.E., Dai, A., Tiffee, J.C., Li, H.H., Mundy, G.R. and Boyce, B.F. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat. Med. 2: 1132-1136, 1996.
19. Hui, S.L., Slemenda, C.W. and Johnston, C.C., Jr. Age and bone mass as predictors of fracture in a prospective study. J. Clin. Invest. 81: 1804-1809, 1988.
20. Ishida, Y., Kondo, T., Kimura, A., Matsushima, K. and Mukaida, N. Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-kappaB activation and a reciprocal suppression of TGF-beta signal pathway. J. Immunol. 176: 5598-5606, 2006.
21. Jiang, D.K., Shen, H., Li, M.X., Jiang, C., Yang, N., Zhu, J., Wu, Y., Qin, Y. J., Zhou, Q. and Deng, H.W. No major effect of the insulin-like growth factor I gene on bone mineral density in premenopausal Chinese women. Bone 36: 694-699, 2005.
22. Koh, J.M., Khang, Y.H., Jung, C.H., Bae, S., Kim, D.J., Chung, Y.E. and Kim, G.S. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos. Int. 16: 1263-1271, 2005.
23. Kristensen, V.N., Tsalenko, A., Geisler, J., Faldaas, A., Grenaker, G., Lingjaerde, O.C., Fjeldstad, S., Yakhini, Z., Lonning, P.E. and Borresen-Dale, A.L. Multilocus analysis of SNP and metabolic data within a given pathway. BMC Genomics 7: 5, 2006.
24. Leung, J.Y., Ho, A.Y., Ip, T.P., Lee, G. and Kung, A.W. The efficacy and tolerability of risedronate on bone mineral density and bone remover markers in osteoporotic Chinese women: a randomized placebo-controlled study. Bone 36: 358-364, 2005.
25. Loktionov, A. Common gene polymorphisms and nutrition: emerging links with pathogenesis of multifactorial chronic diseases (review). J. Nutr. Biochem. 14: 426-451, 2003.
26. Mangino, M., Torrente, I., De Luca, A., Sanchez, O., Dallapiccola, B. and Novelli, G. A single-nucleotide polymorphism in the human bone morphogenetic protein-4 (BMP 4) gene. J. Hum. Genet. 44: 76-77, 1999.
27. Melton, L.J., 3rd, Kan, S.H., Frye, M.A., Wahner, H.W., O'Fallon, W.M. and Riggs, B.L. Epidemiology of vertebral fractures in women. Am J. Epidemiol. 129: 1000-1011, 1989.
28. Mezquita-Raya, P., Munoz-Torres, M., Alonso, G., de Luna, J.D., Quesada, J.M., Dotado, G., Luque-Recio, F., Ruiz-Requena, M.E., Lopez-Rodriguez, F. and Escobar-Jimenez, F. Susceptibility for postmenopausal osteoporosis: interaction between genetic, hormonal and lifestyle factors. Calcif. Tissue Int. 75: 373-379, 2004.
29. Miyao, M., Hosoi, T., Inoue, S., Hoshino, S., Shiraki, M., Orimo, H. and Ouchi, Y. Polymorphism of insulin-like growth factor I gene and bone mineral density. Calcif. Tissue Int. 63: 306-311, 1998.
30. Moffett, S.P., Zmuda, J.M., Oakley, J.I., Beck, TJ., Cauley, J.A., Stone, K.L., Lui, L.Y., Ensrud, K.E., Hillier, T.A., Hochberg, M.C., Morin, P., Peltz, G., Greene, D. and Cummings, S.R. Tumor necrosis factor-alpha polymorphism, bone strength phenotypes, and the risk of fracture in older women. J. Clin. Endocrinol. Metab. 90: 3491-3497, 2005.
31. Mukai, T., Otsuka, F., Otani, H., Yamashita, M., Takasugi, K., Inagaki, K., Yamamura, M. and Makino, H. TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. Biochem. Biophys. Res. Commun. 356: 1004-1010, 2007.
32. Nakamura, M., Zhang, Z.Q., Shan, L., Hisa, T., Sasaki, M., Tsukino, R., Yokoi, T., Kaname, A. and Kakudo, K. Allelic variants of human calcitonin receptor in the Japanese population. Hum. Genet. 99: 38-41, 1997.
33. NIH Consensus Development Panel on Osteoporosis Prevention, D., and Therapy. Osteoporosis prevention, diagnosis, and therapy. J. Am. Med. Assoc. 285: 785-795, 2001.
34. Osmanagaoglu, M.A., Okumus, B., Osmanagaoglu, T. and Bozkaya, H. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women. J. Womens Health (Larchmt) 13: 993-999, 2004.
35. Peacock, M., Liu, G., Carey, M., Ambrosius, W., Turner, C.H., Hui, S. and Johnston, C.C., Jr. Bone mass and structure at the hip in men and women over the age of 60 years. Osteoporos. Int. 8: 231-239, 1998.
36. Phelps, E., Bezouglaia, O., Tetradis, S. and Nervina, J.M. Parathyroid hormone induces receptor activity modifying protein-3 (RAMP3) expression primarily v/a 3′,5′-cyclic adenosine monophosphate signaling in osteoblasts. Calcif. Tissue Int. 77: 96-103, 2005.
37. Ramesh Babu, L., Witson, S.G., Dick, I.M., Islam, F.M., Devine, A. and Prince, R.L. Bone mass effects of a BMP4 gene polymorphism in postmenopausal women. Bone 36: 555-561, 2005.
38. Rizzoli, R., Bonjour, J.P. and Ferrari, S.L. Osteoporosis, genetics and hormones. J. Mol. Endocrinol. 26: 79-94, 2001.
39. Sadat-Ali, M., Al-Habdan, I.M., Al-Mulhim, F.A. and El-Hassan, A.Y. Bone mineral density among postmenopausal Saudi women. Saudi. Med. J. 25: 1623-1625, 2004.
40. Schulte, C.M., Dignass, A.U., Goebell, H., Roher, H.D. and Schulte, K.M. Genetic factors determine extent of bone loss in inflammatory bowel disease. Gastroenterology 119: 909-920, 2000.
41. Summers, K.M. and Brock, T.P. Impact of pharmacist-led community bone mineral density screenings. Ann. Pharmacother. 39: 243-248, 2005.
42. Taboulet, J., Frenkian, M., Frendo, J.L., Feingold, N., Jullienne, A. and de Vernejoul, M.C. Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women. Hum. Mol. Genet. 7: 2129-2133, 1998.
43. Xu, H., Xiong, D.H., Xu, F.H., Zhang, Y.Y., Lei, S.F. and Deng, H.W. Association between VDR ApaI polymorphism and hip bone mineral density can be modified by body mass index: a study on postmenopausal Chinese women. Acta Biochim. Biophys. Sin. (Shanghai) 37: 61-67, 2005.
44. Yamada, Y., Miyauchi, A., Takagi, Y., Tanaka, M., Mizuno, M. and Harada, A. Association of the C-509→T polymorphism, alone of in combination with the T869→C polymorphism, of the transforming growth factor-betal gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women. J. Mol. Med. 79: 149-156, 2001.